文献速递主动脉外科

急性A型主动脉夹层合并肠系膜灌注不良的「TEVAR优先」策略:与常规算法的初步结果比较

The "thoracic endovascular aortic repair-first" strategy for acute type A dissection with mesenteric malperfusion: Initial results compared with conventional algorithms.
PubMed 文献 · J Thorac Cardiovasc Surg · 2019-02-11

本研究回顾Emory主动脉数据库2003至2017年34例急性A型夹层合并肠系膜灌注不良患者,比较四种治疗策略。TEVAR优先(TEVAR-1st)组10例延迟主动脉替换者死亡率为30%,无术后肠坏死或难治性酸中毒;总体死亡率为55.8%。

要点

  • TEVAR优先策略可延迟中心主动脉替换直至终末器官缺血缓解。
  • TEVAR-1st组无术后肠坏死或难治性酸中毒病例。
  • TEVAR-1st组10例延迟主动脉替换者死亡率为30%。

核心结论

  • TEVAR优先策略作为决策桥梁,可能较常规策略改善急性A型夹层合并肠系膜灌注不良患者的生存。

研究设计与样本

  • 回顾性分析Emory主动脉数据库2003至2017年34例急性A型夹层合并肠系膜灌注不良患者,比较四种治疗策略。

主要发现

  • 总体死亡率为55.8%,平均年龄53±13岁,合并肾和髂股灌注不良发生率分别为52%和41%,初始血清乳酸4.3±2.1 mmol/L。
  • 升主动脉/弓部替换后开腹组术后肠坏死或难治性酸中毒发生率为77%,死亡率为69.2%。
  • 腋动脉-双股动脉旁路后升主动脉/弓部替换组全部存活,但66%需术后透析。
  • 升主动脉/弓部替换并顺行TEVAR组死亡率为80%,继发于持续性术后肠坏死或难治性酸中毒。
  • TEVAR-1st组3例在主动脉替换前死亡,10例延迟主动脉替换者死亡率为30%,无术后肠坏死或难治性酸中毒病例。

临床怎么用

  • 对急性A型夹层合并肠系膜灌注不良患者,可考虑TEVAR优先作为决策桥梁,延迟中心主动脉替换直至终末器官缺血缓解。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Acute type A dissection with mesenteric malperfusion is a rare but lethal variant of aortic dissection. This study examines outcomes from various treatment algorithms. METHODS: A review from 2003 to 2017 of the Emory Aortic Database identified 34 patients who presented with acute type A dissection with mesenteric malperfusion. Outcomes from 4 different treatment strategies were analyzed: ascending aortic/arch replacement followed by laparotomy (n = 13), axillary-bifemoral artery bypass followed by ascending/arch replacement (n = 3); ascending/arch and concomitant antegrade thoracic endovascular aortic repair (TEVAR) (n = 5), and TEVAR followed by delayed ascending/arch replacement (TEVAR-1st) (n = 13). RESULTS: The mean age of all patients was 53 ± 13 years and was equivalent among the groups. The incidence of concomitant renal and ileofemoral malperfusion was 52% and 41%, and the initial serum lactate level was 4.3 ± 2.1 mmol/L. Overall mortality was 55.8%. In the ascending aortic/arch replacement followed by laparotomy group, 77% of patients had postoperative bowel necrosis or intractable acidosis and the mortality was 69.2%. All patients in the axillary-bifemoral artery bypass followed by ascending/arch replacement group survived, but 66% required postoperative dialysis. In the ascending/arch and concomitant antegrade/TEVAR group, the mortality was 80% secondary to persistent postoperative bowel necrosis or intractable acidosis. Three patients in the TEVAR-1st group died before aortic replacement. In the 10 patients who underwent TEVAR followed by delayed aortic replacement, the mortality was 30%. There were no cases of postoperative bowel necrosis or intractable acidosis in the TEVAR-1st group. CONCLUSIONS: The TEVAR-1st strategy delays central aortic replacement until end-organ ischemia has resolved. This novel paradigm serves as a bridge to decision, and may improve survival compared with conventional treatment strategies in acute type A dissection with mesenteric malperfusion.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Leshnower BG, Keeling WB, Duwayri YM, et al. The "thoracic endovascular aortic repair-first" strategy for acute type A dissection with mesenteric malperfusion: Initial results compared with conventional algorithms. J Thorac Cardiovasc Surg. 2019. PMID: 30853232. doi:10.1016/j.jtcvs.2019.01.116

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。